Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: EHC AMED ENSG CHE ADUS FMS HCSG SVC SSY OPI

| Held by: IJR VTI IWM VB VBR VXF SPSM IJT IWO SLYG

Index	RUT	P/E	66.38	EPS (ttm)	0.60	Insider Own	36.39%	Shs Outstand	180.69M	Perf Week	-1.80%
Market Cap	7.17B	Forward P/E	29.79	EPS next Y	1.33	Insider Trans	-31.19%	Shs Float	114.72M	Perf Month	1.69%
Enterprise Value	9.73B	PEG	0.69	EPS next Q	0.35	Inst Own	75.10%	Short Float	6.85%	Perf Quarter	21.96%
Income	129.59M	P/S	0.58	EPS this Y	87.51%	Inst Trans	15.16%	Short Ratio	4.29	Perf Half Y	91.34%
Sales	12.41B	P/B	3.95	EPS next Y	27.12%	ROA	1.23%	Short Interest	7.86M	Perf YTD	6.17%
Book/sh	10.06	P/C	51.10	EPS next 5Y	43.36%	ROE	4.25%	52W High	41.26 -3.64%	Perf Year	76.95%
Cash/sh	0.78	P/FCF	22.46	EPS past 3/5Y	- 60.10%	ROIC	2.93%	52W Low	15.48 156.79%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	17.94	Sales past 3/5Y	18.93% 20.01%	Gross Margin	12.30%	Volatility	5.33% 4.12%	Perf 5Y	-
Dividend TTM	-	EV/Sales	0.78	EPS Y/Y TTM	371.04%	Oper. Margin	2.92%	ATR (14)	1.57	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.38	Sales Y/Y TTM	17.23%	Profit Margin	1.04%	RSI (14)	54.97	Recom	1.12
Dividend Gr. 3/5Y	- -	Current Ratio	1.79	EPS Q/Q	641.65%	SMA20	1.37%	Beta	2.39	Target Price	44.47
Payout	-	Debt/Eq	1.48	Sales Q/Q	14.70%	SMA50	5.04%	Rel Volume	0.55	Prev Close	39.68
Employees	600	LT Debt/Eq	1.43	Earnings	Feb 27 BMO	SMA200	40.16%	Avg Volume	1.83M	Price	39.76
IPO	Jan 26, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	21.07% 4.56%	Trades		Volume	1,006,654	Change	0.20%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-12-25	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$45
Dec-11-25	Initiated	Stephens	Overweight	$44
Dec-08-25	Initiated	William Blair	Outperform
Nov-13-25	Initiated	BMO Capital Markets	Outperform	$40
Jun-23-25	Initiated	TD Cowen	Buy	$37
Dec-12-24	Initiated	CJS Securities	Market Outperform
Oct-11-24	Initiated	KeyBanc Capital Markets	Sector Weight
Jun-21-24	Initiated	BTIG Research	Buy	$15
Mar-06-24	Initiated	HSBC Securities	Buy	$13
Feb-27-24	Upgrade	Deutsche Bank	Hold → Buy	$11.50
Feb-20-24	Initiated	Wells Fargo	Overweight	$15
Feb-20-24	Initiated	UBS	Buy	$15
Feb-20-24	Initiated	Morgan Stanley	Overweight	$18
Feb-20-24	Initiated	Leerink Partners	Outperform	$15
Feb-20-24	Initiated	Jefferies	Buy	$18
Feb-20-24	Initiated	Guggenheim	Buy	$15
Feb-20-24	Initiated	Goldman	Buy	$26
Feb-20-24	Initiated	Deutsche Bank	Hold	$11.50
Feb-20-24	Initiated	BofA Securities	Buy	$14

Show Previous Ratings

Feb-09-26 12:04PM	TIG Analyst Raises BrightSpring (BTSG) PT to $55, Cites Consistent Operational Performance (Insider Monkey)
Feb-05-26 11:03PM	2 Reasons to Like BTSG (and 1 Not So Much) (StockStory)
Feb-03-26 04:05PM	BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 (GlobeNewswire)
Jan-16-26 12:13PM	Mizuho Raises BrightSpring (BTSG) PT to $45 Despite Signs of Peak Healthcare Demand (Insider Monkey)
Jan-08-26 08:27AM	Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now? (Zacks)
07:57AM	Loading…
07:57AM	Is This the Right Time to Add Resmed Stock to Your Portfolio? (Zacks)
Jan-07-26 07:35AM	Here's Why You Should Add NVST Stock to Your Portfolio Right Now (Zacks)
07:25AM	IDEXX Stock Up 64.7% in a Year: What's Driving the Growth? (Zacks)
Jan-06-26 09:15AM	Charles River Laboratories International, Inc. (CRL) Hit a 52 Week High, Can the Run Continue? (Zacks)
08:12AM	Should Labcorp Stock Stay in Your Portfolio Right Now? (Zacks)
Jan-03-26 07:20AM	Klaviyo, Wingstop among Stephens Best Ideas for 2026 (TipRanks)
Jan-02-26 07:35AM	Is This the Right Time to Add PBH Stock to Your Portfolio? (Zacks)
07:34AM	Is it the Right Time to Add Insulet Stock to Your Portfolio? (Zacks)
Dec-31-25 04:09PM	Home Care Provider's Growth Impresses As 'Silver Tsunami,' Other Trends Drive Demand (Investor's Business Daily)
08:55AM	Here's What Could Help BrightSpring Health Services, Inc. (BTSG) Maintain Its Recent Price Strength (Zacks)
08:06AM	Loading…
Dec-30-25 08:06AM	Should Myriad Genetics Stock Stay in Your Portfolio Right Now? (Zacks)
07:32AM	Should You Continue to Hold EXAS Stock in Your Portfolio Now? (Zacks)
Dec-26-25 11:40AM	BTSG or MEDP: Which Is the Better Value Stock Right Now? (Zacks)
07:49AM	Should You Continue to Hold BRKR Stock in Your Portfolio? (Zacks)
07:17AM	Reasons to Retain Penumbra Stock in Your Portfolio for Now (Zacks)
Dec-24-25 01:48PM	SOLV Acquires Acera Surgical to Expand Advanced Wound Care Portfolio (Zacks)
08:36AM	Is Quest Diagnostics Stock a Right Pick for Your Portfolio Now? (Zacks)
04:48AM	New Strong Buy Stocks for December 24th (Zacks)
Dec-23-25 02:08PM	Is This the Right Time to Add Veracyte Stock to Your Portfolio? (Zacks)
02:08PM	Abbott Stock May Benefit Following Volt PFA's FDA Approval (Zacks)
Dec-22-25 09:15AM	BrightSpring Health Services, Inc. (BTSG) Hits Fresh High: Is There Still Room to Run? (Zacks)
07:49AM	TMO Stock May Benefit From PPD CorEvitas Alzheimer's Registry Launch (Zacks)
Dec-19-25 03:16PM	Why BrightSpring Health Services (BTSG) Stock Is Trading Up Today (StockStory)
11:05AM	Cencora to Acquire OneOncology to Expand Community Oncology Solutions (Zacks)
09:09AM	National Vision Stock Surges 154.6% in a Year: What's Driving it? (Zacks)
03:11PM	Loading…
Dec-18-25 03:11PM	BrightSpring Health Services (BTSG) Stock Is Up, What You Need To Know (StockStory)
08:36AM	Should You Continue to Hold CRL Stock in Your Portfolio for Now? (Zacks)
07:45AM	Should Investors Hold Chemed Stock in Their Portfolio Now? (Zacks)
Dec-17-25 07:58AM	How the OneStep Partnership Could Drive Growth for ZBH Stock (Zacks)
07:55AM	Should You Retain Teleflex Stock in Your Portfolio Now? (Zacks)
Dec-16-25 03:47PM	The Best Value Stocks to Buy in 2026 (Zacks)
11:37AM	BD Expands BD MAX With IVDR-Approved VIASURE Tests in Europe (Zacks)
07:58AM	Is Phibro Animal Health Stock a Smart Addition to Your Portfolio Now? (Zacks)
07:47AM	TMO Stock Set to Gain From the Expansion of Gibco Bacto Portfolio (Zacks)
Dec-15-25 09:12AM	CVS Stock Gains From Offering MMR Vaccine to South Carolina Residents (Zacks)
08:55AM	BrightSpring Health Services, Inc. (BTSG) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Dec-12-25 07:11AM	Is it Apt to Retain Haemonetics Stock in Your Portfolio Now? (Zacks)
Dec-11-25 08:09AM	Should You Continue to Hold EW Stock in Your Portfolio? (Zacks)
Dec-10-25 11:40AM	BTSG vs. MEDP: Which Stock Is the Better Value Option? (Zacks)
08:34AM	Is it Worth Retaining NEOG Stock in Your Portfolio for Now? (Zacks)
08:31AM	Phibro Animal Health Stock Climbs 59.6% YTD: What's Driving It? (Zacks)
Dec-09-25 07:28AM	ALGN Stock Rises on Thailand Launch of Invisalign With MAOB (Zacks)
07:27AM	Reasons to Hold Tandem Diabetes Stock in Your Portfolio for Now (Zacks)
07:26AM	RMD Stock Set to Gain From FDA Clearance of AI-Enabled Smart Comfort (Zacks)
Dec-08-25 07:56AM	PODD Stock Benefits From FDA Approval of Omnipod 5's Enhancements (Zacks)
Dec-05-25 02:15PM	IPO Stock Of The Week: Health Care Leader BrightSpring Falls Back Into Buying Range (Investor's Business Daily)
08:48AM	MDT Stock Set to Benefit From the FDA Clearance of Hugo RAS System (Zacks)
08:31AM	Reasons to Add Omnicell Stock to Your Portfolio Right Now (Zacks)
Dec-03-25 11:59AM	EHC Opens New Lake Worth Rehab Hospital to Meet Rising Demand (Zacks)
09:40AM	Is BrightSpring Health Services, Inc. (BTSG) Outperforming Other Medical Stocks This Year? (Zacks)
09:34AM	Zacks.com featured highlights include Agnico Eagle Mines, General Motors, Great Lakes Dredge & Dock, BrightSpring Health Services and Everus Construction (Zacks)
Dec-02-25 12:10PM	GM and 4 Stocks With Relative Price Strength to Buy Now (Zacks)
Nov-30-25 09:35PM	BMO Capital Maintains Bullish 12%+ BrightSpring EBITDA Growth Outlook on Drug Contract Wins, Generic Conversions (Insider Monkey)
Nov-26-25 12:20PM	Earnings Estimates Moving Higher for BrightSpring Health Services, Inc. (BTSG): Time to Buy? (Zacks)
Nov-25-25 09:15AM	BrightSpring Health Services, Inc. (BTSG) Hits Fresh High: Is There Still Room to Run? (Zacks)
Nov-24-25 07:00PM	BrightSpring Health Services, 10x Genomics, QuidelOrtho, Medpace, and Fortrea Shares Are Soaring, What You Need To Know (StockStory)
11:40AM	BTSG or MEDP: Which Is the Better Value Stock Right Now? (Zacks)
08:13AM	5 Broker-Liked Stocks to Keep an Eye on Amid the Current Market Swings (Zacks)
Nov-20-25 07:50AM	EMBC Q4 Preview: Product Momentum and Strategy Gains to Support Growth? (Zacks)
Nov-19-25 12:24PM	TDOC Partners With TytoCare to Expand At-Home Exam Capabilities (Zacks)
Nov-17-25 09:41AM	Are Medical Stocks Lagging BrightSpring Health Services, Inc. (BTSG) This Year? (Zacks)
Nov-15-25 11:42PM	UBS Ups BrightSpring Target to $42, Reiterated Buy After Beat-and-Raise Q3 (Insider Monkey)
Nov-13-25 10:34PM	Q3 Earnings Outperformers: BrightSpring Health Services (NASDAQ:BTSG) And The Rest Of The Senior Health, Home Health & Hospice Stocks (StockStory) -5.62%
Nov-07-25 11:40AM	BTSG vs. MEDP: Which Stock Is the Better Value Option? (Zacks)
Nov-04-25 01:34PM	Can Aveanna Drive a Strong Third Quarter on Care-Delivery Momentum? (Zacks)
12:36AM	The 5 Most Interesting Analyst Questions From BrightSpring Health Services's Q3 Earnings Call (StockStory)
Oct-30-25 09:25AM	What To Expect From BrightSpring Health Services Inc (BTSG) Q3 2025 Earnings (GuruFocus.com)
Oct-29-25 08:35AM	BTSG Q3 Deep Dive: Specialty Pharmacy and Infusion Growth Offset Customer Shifts (StockStory)
Oct-28-25 04:55PM	BrightSpring Health Services (NASDAQ:BTSG) Delivers Strong Q3 Numbers (StockStory)
04:05PM	BrightSpring Health Services, Inc. Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance (GlobeNewswire)
11:46AM	Implied Volatility Surging for BrightSpring Health Services Stock Options (Zacks)
Oct-26-25 11:11PM	BrightSpring Health Services (BTSG) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Oct-24-25 12:32AM	1 Growth Stock Set to Flourishand 2 We Turn Down (StockStory)
Oct-20-25 09:20PM	BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase (GlobeNewswire) +5.84%
05:30PM	BrightSpring Health Services, Inc. (BTSG) Tops Q3 Earnings and Revenue Estimates (Zacks)
04:15PM	BrightSpring Announces Secondary Offering of Common Stock and Concurrent Share Repurchase (GlobeNewswire)
04:13PM	BrightSpring Health Services, Inc. Reports Preliminary Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance (GlobeNewswire)
Oct-15-25 02:01PM	Why BrightSpring Health Services (BTSG) Stock Is Up Today (StockStory)
Oct-14-25 06:00PM	BrightSpring Health Services Set to Join S&P SmallCap 600 (PR Newswire)
Oct-13-25 04:40PM	Why BrightSpring Health Services (BTSG) Stock Is Trading Up Today (StockStory)
Oct-09-25 12:10PM	Can BrightSpring Health Services, Inc. (BTSG) Keep the Earnings Surprise Streak Alive? (Zacks)
Oct-08-25 04:05PM	BrightSpring Health Services, Inc. to Announce Third Quarter 2025 Financial Results on October 31, 2025 (GlobeNewswire)
Oct-07-25 12:03AM	3 Reasons to Sell BTSG and 1 Stock to Buy Instead (StockStory)
Sep-20-25 09:40AM	BrightSpring Health Soars Post-IPO on Strong Earnings and Upbeat Analyst Targets (Insider Monkey)
Sep-19-25 12:46AM	BofA Raises BrightSpring Health Services (BTSG) PT on BrightSpring Health to $31, Keeps a Buy Rating (Insider Monkey)
Sep-17-25 01:30AM	This Infusion Therapy Leader Is Undervalued. Buy the Stock. (Barrons.com)
Sep-11-25 02:15PM	Deutsche Bank Raises BrightSpring Health Services (BTSG) PT to $30 Following Strong Q2 Growth (Insider Monkey)
Sep-04-25 11:33PM	Senior Health, Home Health & Hospice Stocks Q2 Earnings: BrightSpring Health Services (NASDAQ:BTSG) Firing on All Cylinders (StockStory)
Aug-15-25 04:00PM	IPO Stock Of The Week: Health Care Leader BrightSpring Eyes Latest Buy Point (Investor's Business Daily)
Aug-13-25 12:02AM	BrightSpring Health Services's Q2 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Aug-12-25 11:51PM	BTSG Q2 Deep Dive: Specialty Pharmacy and Infusion Growth Shape Outlook Amid Market Caution (StockStory) +5.13%
Aug-06-25 10:19AM	Are Options Traders Betting on a Big Move in BrightSpring Health Services Stock? (Zacks)
Aug-05-25 12:00PM	BrightSpring Health Services, Inc. (BTSG) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
09:40AM	Are Medical Stocks Lagging Stryker (SYK) This Year? (Zacks)
Aug-02-25 03:08AM	BrightSpring Health Services Inc (BTSG) Q2 2025 Earnings Call Highlights: Robust Revenue Growth ... (GuruFocus.com)

BrightSpring Health Services, Inc. engages in the provision of a platform of complementary health services delivering and pharmacy solutions for complex populations in home and community settings. It operates under the Pharmacy Solutions and Provider Services segments. The Pharmacy Solutions segment includes infusion and specialty pharmacy, and home and community pharmacy. The Provider Services segment is involved in home health care and community and rehab care. The company was founded in 1974 and is headquartered in Louisville, KY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
KKR Group Partnership L.P.	10% Owner	Oct 22 '25	Sale	28.78	14,745,000	424,390,590	62,351,337	Oct 22 05:52 PM
KKR Phoenix Aggregator L.P.	10% Owner	Oct 22 '25	Sale	28.78	14,745,000	424,390,590	62,351,337	Oct 22 05:48 PM
ROUSSEAU JON B	See Remarks	Oct 22 '25	Option Exercise	6.37	235,000	1,496,950	1,366,930	Oct 22 04:10 PM
ROUSSEAU JON B	See Remarks	Oct 22 '25	Sale	28.78	235,000	6,763,770	1,131,930	Oct 22 04:10 PM
Nalley Lisa A	See Remarks	Oct 22 '25	Option Exercise	6.37	20,000	127,400	151,150	Oct 22 04:09 PM
Nalley Lisa A	See Remarks	Oct 22 '25	Sale	28.78	20,000	575,640	131,150	Oct 22 04:09 PM
McMaude Michael A	Former Officer	Aug 14 '25	Proposed Sale	22.40	16,168	362,241		Aug 14 05:53 PM
KKR Group Partnership L.P.	10% Owner	Jun 24 '25	Sale	21.15	2,100,000	44,418,990	77,096,337	Jun 26 04:31 PM
KKR Phoenix Aggregator L.P.	10% Owner	Jun 24 '25	Sale	21.15	2,100,000	44,418,990	77,096,337	Jun 26 04:30 PM
KKR Group Partnership L.P.	10% Owner	Jun 12 '25	Sale	21.15	13,288,101	281,068,584	79,671,883	Jun 16 08:08 PM
KKR Phoenix Aggregator L.P.	10% Owner	Jun 12 '25	Sale	21.15	13,288,101	281,068,584	79,671,883	Jun 16 08:08 PM
Phipps Jennifer A	Chief Accounting Officer	Jun 12 '25	Option Exercise	6.37	15,616	99,474	245,646	Jun 13 04:04 PM
Phipps Jennifer A	Chief Accounting Officer	Jun 12 '25	Sale	21.75	15,616	339,648	230,030	Jun 13 04:04 PM
Nalley Lisa A	See Remarks	Jun 12 '25	Option Exercise	6.37	14,415	91,824	145,565	Jun 13 04:03 PM
Nalley Lisa A	See Remarks	Jun 12 '25	Sale	21.75	14,415	313,526	131,150	Jun 13 04:03 PM
ROUSSEAU JON B	See Remarks	Jun 12 '25	Option Exercise	6.37	531,840	3,387,821	1,715,973	Jun 13 04:03 PM
ROUSSEAU JON B	See Remarks	Jun 12 '25	Sale	21.75	531,840	11,567,520	1,184,133	Jun 13 04:03 PM
McMaude Michael A	See Remarks	Jun 12 '25	Sale	21.75	119,298	2,594,732	207,590	Jun 13 04:02 PM
Barnes Robert Allen	President, Community Living	Jun 12 '25	Option Exercise	6.37	27,606	175,850	69,999	Jun 13 04:02 PM
Barnes Robert Allen	President, Community Living	Jun 12 '25	Sale	21.75	30,730	668,378	39,269	Jun 13 04:02 PM
Walgreens Boots Alliance, Inc.	Former 10% owner	Feb 18 '25	Sale	21.16	12,000,000	253,920,000	11,239,996	Feb 20 04:30 PM
Walgreen Co.	10% Owner	Feb 18 '25	Proposed Sale	22.15	12,000,000	265,800,000		Feb 18 09:07 PM

Open in Screener

COR

Cencora Inc

Feb 09 • 04:00PM ET

363.27

+4.02 1.12 %

Healthcare • Medical Distribution • USA • NYSE

Peers: CAH MCK HSIC ACH PDCO DXCM BIO HCA LH

| Held by: VTI VOO VO IVV SPY VTV XLV IWP VOE VIG

Index	S&P 500	P/E	43.69	EPS (ttm)	8.31	Insider Own	0.39%	Shs Outstand	194.52M	Perf Week	-0.08%
Market Cap	70.67B	Forward P/E	18.49	EPS next Y	19.64	Insider Trans	-10.32%	Shs Float	193.71M	Perf Month	8.20%
Enterprise Value	76.97B	PEG	1.71	EPS next Q	4.88	Inst Own	95.30%	Short Float	2.52%	Perf Quarter	0.84%
Income	1.63B	P/S	0.22	EPS this Y	10.12%	Inst Trans	0.43%	Short Ratio	3.49	Perf Half Y	27.41%
Sales	325.78B	P/B	37.03	EPS next Y	11.48%	ROA	2.20%	Short Interest	4.89M	Perf YTD	7.56%
Book/sh	9.81	P/C	39.07	EPS next 5Y	10.84%	ROE	152.25%	52W High	377.54 -3.78%	Perf Year	47.59%
Cash/sh	9.30	P/FCF	19.59	EPS past 3/5Y	-0.34% -	ROIC	17.13%	52W Low	237.71 52.82%	Perf 3Y	129.24%
Dividend Est.	2.40 (0.66%)	EV/EBITDA	15.96	Sales past 3/5Y	10.43% 11.09%	Gross Margin	3.25%	Volatility	4.76% 2.72%	Perf 5Y	243.94%
Dividend TTM	2.25 (0.62%)	EV/Sales	0.24	EPS Y/Y TTM	18.24%	Oper. Margin	1.16%	ATR (14)	10.47	Perf 10Y	308.17%
Dividend Ex-Date	Feb 13, 2026	Quick Ratio	0.51	Sales Y/Y TTM	7.45%	Profit Margin	0.50%	RSI (14)	57.48	Recom	1.55
Dividend Gr. 3/5Y	6.14% 5.79%	Current Ratio	0.92	EPS Q/Q	14.47%	SMA20	2.91%	Beta	0.69	Target Price	405.13
Payout	27.63%	Debt/Eq	4.15	Sales Q/Q	5.45%	SMA50	4.62%	Rel Volume	0.82	Prev Close	359.25
Employees	51000	LT Debt/Eq	3.97	Earnings	Feb 04 BMO	SMA200	15.13%	Avg Volume	1.40M	Price	363.27
IPO	Apr 04, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.77% -0.15%	Trades		Volume	1,155,147	Change	1.12%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-29-26	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$400
Jan-22-26	Upgrade	Jefferies	Hold → Buy	$440
Dec-09-25	Initiated	Barclays	Overweight	$400
Jun-03-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$337
Dec-04-24	Resumed	Mizuho	Outperform	$280
Sep-18-24	Downgrade	BofA Securities	Buy → Neutral	$275 → $245
Feb-26-24	Initiated	Leerink Partners	Outperform	$261
Jan-03-24	Initiated	Barclays	Overweight	$242
Dec-14-23	Initiated	Wells Fargo	Equal Weight	$213
Mar-31-23	Initiated	Citigroup	Buy	$185
Jan-31-23	Resumed	Evercore ISI	Outperform	$185
Oct-11-22	Upgrade	BofA Securities	Neutral → Buy	$160 → $169
Aug-22-22	Resumed	Morgan Stanley	Equal-Weight
Jul-11-22	Downgrade	Evercore ISI	Outperform → In-line	$150
Jun-07-22	Upgrade	Deutsche Bank	Hold → Buy	$167 → $178
May-26-22	Upgrade	Barclays	Equal Weight → Overweight
Apr-12-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$178
Apr-01-22	Resumed	Credit Suisse	Outperform	$180
Feb-04-21	Upgrade	Evercore ISI	In-line → Outperform
Jan-06-21	Upgrade	BofA Securities	Underperform → Neutral

Show Previous Ratings

Feb-06-26 09:28AM	Low Volatility ETFs to Watch Amid Major Tech Sell-Off Over AI Panic (Zacks)
Feb-05-26 03:31PM	Cencora (COR) Stock Trades Up, Here Is Why (StockStory) +6.72%
01:58PM	Analyst Report: Cardinal Health, Inc. (Morningstar Research)
12:48PM	Cardinal Health Stock Jumps After Earnings. Its CEO Explains What Went Right. (Barrons.com)
10:35AM	Analyst Report: McKesson Corporation (Morningstar Research)
01:13AM	Loading…
01:13AM	Cencora Q1 Earnings Call Highlights (MarketBeat)
12:34AM	COR Q4 Deep Dive: Specialty Expansion and OneOncology Drive Strategic Shifts (StockStory)
Feb-04-26 11:42PM	Analyst Report: McKesson Corporation (Morningstar Research) -8.79%
04:05PM	Cencora Inc (COR) Q1 2026 Earnings Call Highlights: Strong US Growth Amid International Challenges (GuruFocus.com)
01:44PM	Analyst Report: Cencora, Inc. (Morningstar Research)
11:59AM	Cencora Stock Down Despite Q1 Earnings Beat, Gross Margin Improves (Zacks)
11:32AM	Cencora Lifts 2026 Sales Outlook Despite Q1 Revenue Miss (Benzinga)
11:12AM	Rotation out of Tech Stocks Weighs on the Broader Market (Barchart)
10:04AM	Cencora (COR) Q1 2026 Earnings Call Transcript (Motley Fool)
10:03AM	Stocks Mixed on Sector Rotation out of Tech (Barchart)
09:30AM	Loading…
09:30AM	Cencora (COR) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
07:40AM	Cencora (COR) Q1 Earnings Top Estimates (Zacks)
06:47AM	Cencora (NYSE:COR) Misses Q4 CY2025 Revenue Estimates (StockStory)
06:38AM	Cencora: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
06:30AM	Cencora Reports Fiscal 2026 First Quarter Results (Business Wire)
Feb-02-26 10:06PM	Cencora (COR) Reports Earnings Tomorrow: What To Expect (StockStory)
Feb-01-26 07:47AM	January jobs data, Alphabet and Amazon earnings, more Warsh fallout: What to watch this week (Yahoo Finance)
Jan-31-26 09:36AM	Analysts Lift Ratings and Price Targets as Cencora, Inc. (COR)'s Growth Story Gains Momentum (Insider Monkey)
Jan-30-26 09:15AM	Exploring Analyst Estimates for Cencora (COR) Q1 Earnings, Beyond Revenue and EPS (Zacks)
Jan-29-26 09:35AM	First Solar downgraded, Fortinet upgraded: Wall Street's top analyst calls (The Fly)
08:33AM	Can Specialty and International Momentum Support Cencora's Q1 Results? (Zacks)
Jan-27-26 08:09PM	Analyst Report: Cencora, Inc. (Morningstar Research)
Jan-26-26 01:27PM	IBD Stock Of The Day: Why Cardinal Health's Momentum Is 'Special' And Not Over Yet (Investor's Business Daily)
Jan-25-26 04:46AM	Here Are the Top Four Blue-Chip Stocks To Buy in 2026, According to WarrenAI (Investing.com)
Jan-22-26 07:30AM	Cencora Elects Ellen Cooper to Its Board of Directors (Business Wire)
07:51AM	Loading…
Jan-12-26 07:51AM	3 Medical Supplies Stocks That Beat the Market Despite Macro Headwinds (Zacks)
Jan-09-26 09:06AM	What to Expect From Cencora's Next Quarterly Earnings Report (Barchart)
Jan-08-26 08:40PM	Analyst Report: Cencora, Inc. (Morningstar Research)
09:40AM	Why Cencora (COR) is a Top Value Stock for the Long-Term (Zacks)
07:57AM	Here's Why You Should Retain Cencora Stock in Your Portfolio Now (Zacks)
Jan-07-26 09:45AM	Here's Why Cencora (COR) is a Strong Growth Stock (Zacks)
Jan-06-26 04:30PM	Cencora Announces Date and Time for First Quarter Fiscal 2026 Earnings Release (Business Wire)
Jan-05-26 01:44PM	McKesson Builds Earnings Momentum on Specialty and Automation (Zacks)
Dec-30-25 07:33AM	Reasons to Add Cooper Companies Stock to Your Portfolio Now (Zacks)
Dec-29-25 10:17AM	Take the Zacks Approach to Beat the Markets: Castle Biosciences, Hamilton Insurance & Monster Beverage in Focus (Zacks)
08:52AM	Here's Why You Should Retain Glaukos Stock in Your Portfolio Now (Zacks)
Dec-26-25 07:18AM	Reasons to Retain Baxter International Stock in Your Portfolio Now (Zacks)
Dec-24-25 10:36PM	Q3 Rundown: Cencora (NYSE:COR) Vs Other Health Insurance Providers Stocks (StockStory)
09:11AM	These 3 Medical Stocks Have Wall Street's Bullish Vote for 2026 (Zacks)
Dec-23-25 02:09PM	Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now (Zacks)
09:35AM	Zacks.com featured highlights include NVIDIA, Ralph Lauren, Expedia and Cencora (Zacks)
Dec-22-25 10:40AM	4 Stocks Trading Near 52-Week High With More Upside Potential (Zacks)
Dec-19-25 02:14PM	Jim Cramer Says "I like Cencora A Lot" But Notes "Cardinal Health's Got Them All Beat" (Insider Monkey)
11:05AM	Cencora to Acquire OneOncology to Expand Community Oncology Solutions (Zacks)
Dec-18-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Dec-17-25 09:45AM	Why Cencora (COR) is a Top Growth Stock for the Long-Term (Zacks)
Dec-16-25 03:52AM	Cencora takes majority stake in cancer care platform OneOncology for $5B (Healthcare Dive)
Dec-15-25 08:01PM	Lightning Round: Sell BP, says Jim Cramer (CNBC TV)
02:50PM	Analyst Report: Cencora, Inc. (Morningstar Research)
09:06AM	Take the Zacks Approach to Beat the Markets: Liquidia, Western Digital & Johnson & Johnson in Focus (Zacks)
07:00AM	Cencora Accelerates OneOncology Acquisition, Extending Solutions Offering for Community Oncology (Business Wire)
Dec-10-25 08:59AM	Here's Why You Should Add Cencora Stock to Your Portfolio Now (Zacks)
Dec-09-25 09:40AM	Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year? (Zacks)
Dec-05-25 11:30AM	Why Is Cencora (COR) Down 6.3% Since Last Earnings Report? (Zacks)
Dec-03-25 03:26PM	Why Cencora (COR) Shares Are Trading Lower Today (StockStory)
02:59PM	JPMorgan Raises Cencora (COR) Price Target After Financial Model Update (Insider Monkey)
03:35AM	How Is Cencoras Stock Performance Compared to Other Medical Stocks? (Barchart)
Dec-02-25 12:00PM	Cencora (COR) Upgraded to Buy: Here's Why (Zacks)
09:40AM	Here's Why Cencora (COR) is a Strong Value Stock (Zacks)
Dec-01-25 09:45AM	Here's Why Cencora (COR) is a Strong Growth Stock (Zacks)
09:20AM	Take the Zacks Approach to Beat the Markets: MBX Biosciences, Garrett Motion & Monster Beverage in Focus (Zacks)
Nov-28-25 07:08AM	CVS Health Delivers MBR Improvement: Is More Progress in the Cards? (Zacks)
Nov-26-25 09:09AM	GEHC Stock Gains Post Latest Launch to Optimize Radiology Workflows (Zacks)
Nov-25-25 09:50AM	Here's Why Cencora (COR) is a Strong Momentum Stock (Zacks)
Nov-24-25 09:15AM	Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run? (Zacks)
Nov-21-25 09:40AM	Are Medical Stocks Lagging Cencora, Inc. (COR) This Year? (Zacks)
Nov-18-25 09:15AM	Progyny, Inc. (PGNY) Hit a 52 Week High, Can the Run Continue? (Zacks)
Nov-17-25 08:40AM	Take the Zacks Approach to Beat the Markets: Macy's, United Natural Foods & Monster Beverage in Focus (Zacks)
Nov-14-25 09:45AM	Here's Why Cencora (COR) is a Strong Growth Stock (Zacks)
Nov-13-25 09:40AM	Why Cencora (COR) is a Top Value Stock for the Long-Term (Zacks)
Nov-12-25 12:36AM	The 5 Most Interesting Analyst Questions From Cencora's Q3 Earnings Call (StockStory)
Nov-11-25 04:51AM	Cencora Stock: Is Wall Street Bullish or Bearish? (Barchart)
Nov-07-25 09:50AM	Why Cencora (COR) is a Top Momentum Stock for the Long-Term (Zacks)
Nov-06-25 04:45PM	Cencora makes $1 billion investment in pharma supply chains (FreightWaves)
06:21AM	Cencora to invest $1bn in US pharma distribution network (Pharmaceutical Technology)
12:34AM	COR Q3 Deep Dive: Specialty Expansion and Portfolio Restructuring Drive Strategic Focus (StockStory)
Nov-05-25 09:36PM	Analyst Report: McKesson Corporation (Morningstar Research)
04:00PM	Cencora Inc (COR) Q4 2025 Earnings Call Highlights: Strategic Investments Propel Growth Amid ... (GuruFocus.com)
02:59PM	Analyst Report: Cencora, Inc. (Morningstar Research)
11:54AM	Rigetti Computing to Post Q3 Earnings: What's in Store for the Stock? (Zacks)
10:56AM	COR Q4 Earnings & Revenues Beat Estimates, Gross Margin Improves (Zacks)
09:30AM	Cencora (COR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
07:40AM	Cencora (COR) Q4 Earnings and Revenues Surpass Estimates (Zacks)
07:00AM	Drug Distributor Cencora to Invest $1 Billion in U.S. Supply Chain (The Wall Street Journal)
06:44AM	Cencora's (NYSE:COR) Q3 Sales Top Estimates (StockStory)
06:39AM	Cencora: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
06:30AM	Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results (Business Wire)
Nov-04-25 06:35PM	Agilon Health (AGL) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
08:39AM	Solventum to Post Q3 Earnings: Is a Beat Likely for the Stock? (Zacks)
08:39AM	DENTSPLY SIRONA to Post Q3 Earnings: What's in Store for the Stock? (Zacks)
08:38AM	Will Strong Segmental Performance Drive MCK's Top Line in Q2? (Zacks)
Nov-03-25 10:11PM	Earnings To Watch: Cencora (COR) Reports Q3 Results Tomorrow (StockStory)
Oct-31-25 10:15AM	Prescription for Beats: 3 Healthcare Stocks Set to Outperform in Q3 (Zacks)
09:15AM	Countdown to Cencora (COR) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
09:00AM	Stocks making big moves this week: Cencora, Custom Truck One Source, Kirby, Mister Car Wash, and Cardinal Health (StockStory)

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment is involved in the offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers. The International Healthcare Solutions segment includes businesses that focus on international pharmaceutical wholesale and related service operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mauch Robert P.	President & CEO	Jan 20 '26	Option Exercise	86.09	3,763	323,957	71,822	Jan 22 04:43 PM
Mauch Robert P.	President & CEO	Jan 20 '26	Sale	354.73	5,096	1,807,704	66,726	Jan 22 04:43 PM
Mauch Robert P.	Officer	Jan 20 '26	Proposed Sale	354.73	5,096	1,807,704		Jan 20 11:14 AM
Battaglia Silvana	Executive Vice President	Dec 19 '25	Sale	345.00	1,677	578,565	18,796	Dec 22 04:15 PM
Campbell Elizabeth S	Executive Vice President	Dec 19 '25	Sale	342.10	3,351	1,146,377	23,891	Dec 22 04:15 PM
Mauch Robert P.	President & CEO	Dec 18 '25	Option Exercise	86.09	3,763	323,957	73,155	Dec 22 04:14 PM
Mauch Robert P.	President & CEO	Dec 18 '25	Sale	343.45	5,096	1,750,221	68,059	Dec 22 04:14 PM
Campbell Elizabeth S	Officer	Dec 19 '25	Proposed Sale	342.10	3,351	1,146,377		Dec 19 04:15 PM
Krikorian Lazarus	SVP & Chief Accounting Officer	Dec 17 '25	Sale	343.24	4,031	1,383,580	17,154	Dec 19 04:04 PM
Cleary James F	Chief Financial Officer	Dec 17 '25	Option Exercise	86.09	45,154	3,887,308	180,095	Dec 19 04:03 PM
Battaglia Silvana	Officer	Dec 19 '25	Proposed Sale	345.00	1,677	578,565		Dec 19 11:03 AM
Mauch Robert P.	Officer	Dec 18 '25	Proposed Sale	343.45	5,096	1,750,221		Dec 18 09:48 AM
Krikorian Lazarus	Officer	Dec 17 '25	Proposed Sale	343.24	4,031	1,383,580		Dec 17 03:55 PM
Mauch Robert P.	President & CEO	Nov 18 '25	Option Exercise	86.09	3,763	323,957	70,842	Nov 19 05:09 PM
Mauch Robert P.	President & CEO	Nov 18 '25	Sale	366.64	5,096	1,868,397	65,746	Nov 19 05:09 PM
Mauch Robert P.	Officer	Nov 18 '25	Proposed Sale	366.64	5,096	1,868,397		Nov 18 11:43 AM
COLLIS STEVEN H	Former Officer & Director	Nov 18 '25	Proposed Sale	366.64	31,349	11,493,797		Nov 18 10:40 AM
COLLIS STEVEN H	Former Officer & Director	Nov 06 '25	Proposed Sale	355.25	50,000	17,762,554		Nov 06 04:16 PM
Verma Pawan	EVP, Chief Data & Info Officer	Oct 31 '25	Option Exercise	337.81	8,537	2,883,884	8,551	Nov 04 04:15 PM
Mauch Robert P.	President & CEO	Oct 20 '25	Option Exercise	86.09	3,763	323,957	43,037	Oct 21 04:33 PM
Mauch Robert P.	President & CEO	Oct 20 '25	Sale	326.80	5,097	1,665,700	37,940	Oct 21 04:33 PM
COLLIS STEVEN H	Former Officer & Director	Oct 21 '25	Proposed Sale	326.99	31,350	10,251,105		Oct 21 04:16 PM
Mauch Robert P.	Officer	Oct 20 '25	Proposed Sale	326.80	5,097	1,665,700		Oct 20 09:36 AM
Campbell Elizabeth S	Executive Vice President	Oct 01 '25	Sale	313.28	1,886	590,846	12,824	Oct 03 04:01 PM
Campbell Elizabeth S	Officer	Oct 01 '25	Proposed Sale	313.28	1,886	590,846		Oct 01 10:36 AM
Mauch Robert P.	President & CEO	Sep 18 '25	Option Exercise	86.09	3,763	323,957	44,371	Sep 22 04:16 PM
Mauch Robert P.	President & CEO	Sep 18 '25	Sale	290.00	5,097	1,478,130	39,274	Sep 22 04:16 PM
COLLIS STEVEN H	Executive Chairman	Sep 16 '25	Option Exercise	86.09	29,350	2,526,742	337,263	Sep 18 03:56 PM
COLLIS STEVEN H	Executive Chairman	Sep 16 '25	Sale	289.86	31,350	9,087,142	305,913	Sep 18 03:56 PM
Mauch Robert P.	Officer	Sep 18 '25	Proposed Sale	290.00	5,097	1,478,130		Sep 18 11:54 AM
COLLIS STEVEN H	Director	Sep 16 '25	Proposed Sale	291.55	31,350	9,140,092		Sep 16 10:27 AM
COLLIS STEVEN H	Executive Chairman	Aug 19 '25	Option Exercise	86.09	12,579	1,082,926	322,492	Aug 20 04:08 PM
COLLIS STEVEN H	Executive Chairman	Aug 19 '25	Sale	289.98	14,579	4,227,618	307,913	Aug 20 04:08 PM
Mauch Robert P.	President & CEO	Aug 18 '25	Option Exercise	86.09	3,225	277,640	45,576	Aug 20 04:06 PM
Mauch Robert P.	President & CEO	Aug 18 '25	Sale	293.53	4,968	1,458,257	40,608	Aug 20 04:06 PM
COLLIS STEVEN H	Director	Aug 19 '25	Proposed Sale	289.98	14,579	4,227,618		Aug 19 09:51 AM
Mauch Robert P.	Officer	Aug 18 '25	Proposed Sale	293.53	4,968	1,458,257		Aug 18 11:06 AM
COLLIS STEVEN H	Executive Chairman	Jul 22 '25	Option Exercise	86.09	12,578	1,082,840	324,491	Jul 23 04:30 PM
COLLIS STEVEN H	Executive Chairman	Jul 22 '25	Sale	292.67	14,578	4,266,543	309,913	Jul 23 04:30 PM
Mauch Robert P.	President & CEO	Jul 18 '25	Option Exercise	86.09	3,225	277,640	47,319	Jul 22 04:23 PM
Mauch Robert P.	President & CEO	Jul 18 '25	Sale	294.11	4,968	1,461,138	42,351	Jul 22 04:23 PM
COLLIS STEVEN H	Director	Jul 22 '25	Proposed Sale	292.67	14,578	4,266,543		Jul 22 09:47 AM
Mauch Robert P.	Officer	Jul 18 '25	Proposed Sale	294.11	4,968	1,461,138		Jul 18 11:44 AM
COLLIS STEVEN H	Executive Chairman	Jun 24 '25	Option Exercise	86.09	12,579	1,082,926	326,492	Jun 25 04:03 PM
COLLIS STEVEN H	Executive Chairman	Jun 24 '25	Sale	292.62	14,579	4,266,107	311,913	Jun 25 04:03 PM
COLLIS STEVEN H	Director	Jun 24 '25	Proposed Sale	292.62	14,579	4,266,107		Jun 24 10:21 AM
Battaglia Silvana	Executive Vice President	Jun 18 '25	Sale	297.40	4,077	1,212,520	11,297	Jun 20 04:06 PM
Mauch Robert P.	President & CEO	Jun 18 '25	Option Exercise	86.09	3,225	277,640	49,063	Jun 20 04:04 PM
Mauch Robert P.	President & CEO	Jun 18 '25	Sale	295.30	4,969	1,467,346	44,094	Jun 20 04:04 PM
Lon Greenberg	Board of directors	Jun 18 '25	Proposed Sale	293.20	1,000	293,200		Jun 18 04:40 PM
Battaglia Silvana	Officer	Jun 18 '25	Proposed Sale	297.41	4,077	1,212,520		Jun 18 12:58 PM
Mauch Robert P.	Officer	Jun 18 '25	Proposed Sale	295.30	4,969	1,467,346		Jun 18 09:50 AM
Krikorian Lazarus	SVP & Chief Accounting Officer	May 29 '25	Sale	288.96	3,000	866,881	17,154	Jun 02 04:08 PM
Krikorian Lazarus	Officer	May 29 '25	Proposed Sale	288.96	3,000	866,881		May 29 11:37 AM
Mauch Robert P.	President & CEO	May 19 '25	Option Exercise	86.09	3,225	277,640	50,807	May 21 04:04 PM
Mauch Robert P.	President & CEO	May 19 '25	Sale	291.43	4,969	1,448,116	45,838	May 21 04:04 PM
COLLIS STEVEN H	Executive Chairman	May 20 '25	Option Exercise	86.09	12,578	1,082,840	328,491	May 21 04:00 PM
COLLIS STEVEN H	Executive Chairman	May 20 '25	Sale	293.84	14,578	4,283,600	313,913	May 21 04:00 PM
COLLIS STEVEN H	Director	May 20 '25	Proposed Sale	293.84	14,578	4,283,600		May 20 09:45 AM
Hopfield Jessica	Member of immediate family of	May 19 '25	Proposed Sale	293.24	12,185	3,573,163		May 19 02:29 PM
Mauch Robert P.	Officer	May 19 '25	Proposed Sale	291.43	4,969	1,448,116		May 19 09:51 AM
GREENBERG LON R	Director	May 14 '25	Sale	279.05	3,000	837,150	17,851	May 16 04:23 PM
GREENBERG LON R	Director	May 14 '25	Proposed Sale	279.05	3,000	837,150		May 14 03:53 PM
COLLIS STEVEN H	Executive Chairman	Apr 22 '25	Option Exercise	86.09	12,579	1,082,926	330,492	Apr 23 04:24 PM
COLLIS STEVEN H	Executive Chairman	Apr 22 '25	Sale	281.81	14,579	4,108,508	315,913	Apr 23 04:24 PM
Mauch Robert P.	President & CEO	Apr 21 '25	Option Exercise	86.09	3,225	277,640	52,551	Apr 22 04:06 PM
Mauch Robert P.	President & CEO	Apr 21 '25	Sale	289.33	4,969	1,437,681	47,582	Apr 22 04:06 PM
COLLIS STEVEN H	Director	Apr 22 '25	Proposed Sale	281.81	14,579	4,108,508		Apr 22 09:42 AM
Mauch Robert P.	Officer	Apr 21 '25	Proposed Sale	289.33	4,969	1,437,681		Apr 21 09:48 AM
COLLIS STEVEN H	Executive Chairman	Mar 25 '25	Option Exercise	86.09	12,578	1,082,840	332,491	Mar 26 04:40 PM
COLLIS STEVEN H	Executive Chairman	Mar 25 '25	Sale	269.51	14,578	3,928,917	317,913	Mar 26 04:40 PM
Campbell Elizabeth S	Executive Vice President	Mar 24 '25	Sale	268.28	4,127	1,107,192	14,665	Mar 26 04:38 PM
COLLIS STEVEN H	Director	Mar 25 '25	Proposed Sale	269.51	14,578	3,928,917		Mar 25 10:16 AM
Campbell Elizabeth S	Officer	Mar 24 '25	Proposed Sale	268.28	4,127	1,107,192		Mar 24 10:53 AM
Mauch Robert P.	President & CEO	Mar 18 '25	Option Exercise	86.09	3,226	277,726	54,296	Mar 19 04:38 PM
Mauch Robert P.	President & CEO	Mar 18 '25	Sale	260.93	4,970	1,296,822	49,326	Mar 19 04:38 PM
Mauch Robert P.	Officer	Mar 18 '25	Proposed Sale	260.93	4,970	1,296,822		Mar 18 12:05 PM
Krikorian Lazarus	SVP & Chief Accounting Officer	Mar 10 '25	Sale	260.06	2,000	520,120	20,154	Mar 11 04:07 PM
Krikorian Lazarus	Officer	Mar 10 '25	Proposed Sale	260.06	2,000	520,120		Mar 10 02:09 PM
Mauch Robert P.	President & CEO	Mar 03 '25	Option Exercise	86.09	3,226	277,726	54,296	Mar 04 05:35 PM
Mauch Robert P.	President & CEO	Mar 03 '25	Sale	255.00	4,970	1,267,350	51,070	Mar 04 05:35 PM
Mauch Robert P.	Officer	Mar 03 '25	Proposed Sale	255.00	4,970	1,267,350		Mar 03 03:28 PM
COLLIS STEVEN H	Executive Chairman	Feb 27 '25	Option Exercise	86.09	12,579	1,082,926	332,492	Feb 28 04:05 PM
COLLIS STEVEN H	Executive Chairman	Feb 27 '25	Sale	251.08	14,579	3,660,495	319,913	Feb 28 04:05 PM
COLLIS STEVEN H	Director	Feb 27 '25	Proposed Sale	251.08	14,579	3,660,495		Feb 27 11:26 AM
Battaglia Silvana	Executive Vice President	Feb 21 '25	Sale	242.24	5,000	1,211,200	15,374	Feb 24 05:25 PM
Battaglia Silvana	Officer	Feb 21 '25	Proposed Sale	242.24	5,000	1,211,200		Feb 21 12:18 PM

BTSG

BrightSpring Health Services Inc

COR

Cencora Inc

Upgrade your FINVIZ experience